RA Patients' use of smart injector tracked for better outcomes
NCT ID NCT05891600
First seen Nov 20, 2025 · Last updated May 14, 2026 · Updated 27 times
Summary
This study followed 60 adults with rheumatoid arthritis in Colombia to see how well they stuck to their etanercept injections using a smart device called Smartclic. Researchers checked medical records and pharmacy data over 40 weeks to measure adherence, disease activity, and physical function. The goal was to understand if the device helps patients manage their condition better.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Biomab Ips S.A.S.
Bogotá, 110231, Colombia
Conditions
Explore the condition pages connected to this study.